Page 140 of 282: studies 1,391 to 1,400 of 2,815, newest first. Back to the LSD overview
JAMA March 7, 1964 Roy R. Grinker 16 citations
For several years, quietly and without publicity, several scientists have been studying the behavioral pharmacology of lysergic acid diethylamide (LSD-25), and lately psilocybin, on experimental animals and human subjects. The psychotic effects of these drugs have some but not complete similarity to the schizophrenic psychoses, which has resulted in their classification as psychomimetics. Yet...
American Journal of Psychiatry February 1, 1964 Eliere J. Tolan, F. A. Lingl 37 citations
Two teen-age cases of toxic psychosis associated with gasoline inhalation are described and compared with the so-called "model psychoses" evoked by mescaline, LSD =25 and psilocybin. The symptoms were predominantly autonomic, perceptual and affective. The perceptual experiences included much personnally significant symbolic content. The inhaling of gasoline quickly became a tempting recurrent...
JAMA September 14, 1963 Dana L. Farnsworth 11 citations
An article on stramonium intoxication in this issue ofThe Journal(p 882) calls attention to a growing medical and social problem in this country—the ingestion of a number of drugs which have the common property of drastically altering sensory perception. The drugs all produce hallucinations. In addition to stramonium, the drugs include mescaline or peyote, lysergic acid diethylamide (LSD-25),...
Archives of Neurology July 1, 1963 Jun Wada 41 citations
Introduction The significance to behavior of biologically active amines normally present in the mammalian brain has been receiving increased attention by workers in diversified fields in recent years. This trend has been accelerated by the recognition that a number of potent psychotherapeutic agents seem to assert their beneficial effects by influencing these amines in various ways. For...
Archives of Neurology And Psychiatry March 1, 1959 Elliot D. Luby 920 citations
Introduction The production of model psychoses has been employed as a technique for testing hypotheses relevant to the causes, correlates, and treatment of schizophrenia since 1921, when De Jong demonstrated experimental catatonia by giving bulbocapnine to animals.5This method of study has received considerable impetus with the discovery of the hallucinogenic properties of lysergic acid...
Journal of Mental Science October 1, 1958 Frances R. Ames 184 citations
This paper describes an inquiry into the effects of giving oral doses of the narcotic drug variously known as hashish, marihuana and, in South Africa, dagga. The drug is a preparation from the plant Cannabis sativa whose narcotic effect has been known for centuries. The writer's interest in it was inspired by the work in recent years on the mental disturbances produced by the active principles...
American Journal of Psychiatry April 1, 1957 Harry H. Pennes, Paul H. Hoch 89 citations
Harmine, Win-2299, and Nalline in single dosage produce many new mental effects in schizophrenics grossly similar to those elicited by mescaline and LSD. Many of the same effects are reported in normals after harmine and Nalline (other workers). unlike mescaline and LSD at usual dosage levels, the present psychotomimetics regularly produce drowsiness and sleep along with the aberrant mental...
Experimental Biology and Medicine 1956 E. Costa 64 citations
SummaryTranquilizing drugs: Frenquel (0.8 mg/1), chlorpromazine (0.1 mg/1) and reserpine (0.4 mg/1), antagonize serotonin-induced uterine contractions, though they do not affect sensitivity of the uterus of the spayed rat either to ACh or oxytocin. The period of antagonism is longer lasting with reserpine than with chlorpromazine and is shortest with Frenquel. Mescaline (0.1 mg/1) causes a...
The Journal of Psychology July 1, 1954 Carney Landis, Johs. Clausen 23 citations
(1954). Certain Effects of Mescaline and Lysergic Acid on Psychological Functions. The Journal of Psychology: Vol. 38, No. 1, pp. 211-221.
Frontiers in Psychology October 27, 2026 Nasiru Mohammed Abdullahi, Rashid Menhas, Patience Osose Nasir et al.
Background: Clinical research on psychedelic-assisted therapy (PAT) has expanded substantially in recent years, particularly for post-traumatic stress disorder (PTSD) and depressive disorders. Contemporary studies have generally evaluated psychedelic administration within controlled therapeutic settings that include psychological support, preparation, and integration. However, variability in...